
Education and Training
- Fellow in Medical Oncology, Medicine, Johns Hopkins University, 1995 - 1998
- Medical Resident, Medicine, Johns Hopkins University, 1992 - 1995
- M.D., Duke University, 1992
Grants
- Calithera CX-839-008
- Disparities in the Use of Oral Anticancer Agents in Kidney Cancer
- Race-related germline genetic variation and response to secondary hormonal therapy in metastatic castration-resistant prostate cancer
- Race-Related Alternative Splicing: Novel Targets in Prostate Cancer
- A Phase II open-label, Multicenter study of Apalutamide, Abiraterone Acetate and Prednisone in African American and Caucasian men with metastatic castrate-resistant prostate cancer
- Therapeutic targeting of cystine addiction of renal cell carcinoma
- PCRP Clinical Consortium: Duke University Clinical Research Site
- Plasma Angiome and Serum Androgens as Predictors of Overall Survival in Metastatic Prostate Cancer
- Plasma Angiome and Serum Androgens as Predictors of Overall Survival in Metastatic Prostate Cancer
- A Phase 2 Efficacy and Safety Study of Niraparib in Men with Metastatic Castration-resistant Prostate Cancer and DNA-Repair Anomalies
- Targeting RNA splicing in race-related aggressive and lethal prostate cancer
- Validation and interrogation of differentially expressed and alternatively spliced genes in African American prostate ca
- Development of Circulating Molecular Predictors of Chemotherapy and Novel Hormonal Therapy Benefit in Men with Metastatic Castration Resistant Prostate Cancer (mCRPC)
- An IND-enabling Trial to Determine the Number and Volume of Injections Necessary for Adequate Distribution Throughout Cancer Metastases and to Validate Poliovirus Receptor (CD155) Expression in PC
- ABI-RACE
- Conditional lethality of copper and disulfiram as a therapeutic modality for prostate cancer